8-K: Diversified Healthcare Trust Reports Mixed Q1 2024 Results, SHOP Segment Shows Strong Growth

Diversified Healthcare Trust announced its first quarter 2024 financial results, highlighting a significant increase in same property cash basis NOI driven by the SHOP segment, alongside a net loss.

Summary

• Diversified Healthcare Trust (DHC) reported a net loss of $86.3 million, or $0.36 per share, for the first quarter of 2024.
• Normalized Funds From Operations (FFO) was $3.5 million, or $0.01 per share.
• The company experienced a 9.5% year-over-year increase in same property cash basis Net Operating Income (NOI).
• The Senior Housing Operating Portfolio (SHOP) segment saw a 43% increase in NOI and a 200 basis point occupancy increase to 78.9%.
• Medical Office and Life Science Portfolio achieved 11% rent growth for signed leases during the quarter.
• DHC's portfolio includes 371 properties with a gross book value of $7.2 billion as of March 31, 2024.
• The company had approximately $208.2 million in cash and cash equivalents as of March 31, 2024.
• DHC sold one property for $3.6 million and acquired 34% of AlerisLife common shares for $14.9 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to the significant net loss and decrease in FFO, offset by positive growth in the SHOP segment and rent growth in the Medical Office and Life Science Portfolio. The mixed results and ongoing challenges create uncertainty.

Positives

• The SHOP segment demonstrated strong performance with significant NOI and occupancy growth.
• The Medical Office and Life Science Portfolio showed robust rent growth, indicating strong demand.
• DHC's same property cash basis NOI increased by 9.5% year-over-year.
• The company has a diversified portfolio across various healthcare sectors and geographies.
• DHC has a significant amount of assets under management by The RMR Group.

Negatives

• DHC reported a net loss of $86.3 million, or $0.36 per share, for the quarter.
• Normalized FFO was $3.5 million, or $0.01 per share, which is down significantly year over year.
• Occupancy in the Medical Office and Life Science Portfolio decreased by 400 basis points to 82.9%.
• The company's net loss per share decreased by 63.6% year over year.
• Normalized FFO per share decreased by 80% year over year.

Risks

• The company faces risks related to market conditions, interest rates, and inflation.
• There are risks associated with the financial health of DHC's operators and tenants.
• DHC is exposed to potential conflicts of interest with related parties.
• The company's ability to maintain its REIT status is subject to complex rules.
• DHC is exposed to risks related to government regulations and healthcare reimbursement rates.
• The company faces risks related to competition in the real estate industry.
• DHC's ability to manage capital expenditures and operating costs effectively is a risk.
• The company's ability to raise and balance debt and equity capital is a risk.

Future Outlook

The company's guidance from the fourth quarter 2023 earnings call remains unchanged, and DHC continues to advance key initiatives to strengthen its capital and liquidity position and drive performance across its portfolio.

Management Comments

• Christopher Bilotto, President and Chief Executive Officer, stated that first quarter results were highlighted by a 9.5% year over year increase in same property cash basis NOI and ongoing progress within the SHOP segment.
• Mr. Bilotto also noted that the Medical Office and Life Science Portfolio achieved 11% rent growth for signed leases during the quarter.
• Management stated that they continue to advance key initiatives to further strengthen their capital and liquidity position and drive performance across their portfolio.

Industry Context

The results reflect a mixed performance in the healthcare REIT sector, with strong growth in senior housing operations but challenges in overall profitability. The rent growth in the medical office and life science sector is a positive sign, indicating continued demand in these areas. The company's focus on strengthening its capital position is in line with broader industry trends of managing debt and liquidity in a volatile market.

Comparison to Industry Standards

• DHC's 9.5% increase in same-property cash basis NOI is a strong result compared to some peers in the healthcare REIT sector, but the net loss is a concern.
• Companies like Welltower (WELL) and Ventas (VTR) also focus on senior housing and medical office properties, and their performance in these segments can be used as a benchmark.
• The 11% rent growth in DHC's Medical Office and Life Science Portfolio is competitive with other REITs in this space, such as Alexandria Real Estate Equities (ARE).
• DHC's SHOP segment's 43% NOI growth is notable, as many senior housing operators are still recovering from the pandemic's impact.
• The occupancy rate of 78.9% in the SHOP segment is still below pre-pandemic levels for many operators, indicating room for further improvement.

Stakeholder Impact

• Shareholders will be concerned about the net loss and reduced FFO, but encouraged by the growth in the SHOP segment.
• Employees may be impacted by any changes in operations or cost-cutting measures.
• Tenants in the Medical Office and Life Science Portfolio may see increased rents.
• Operators of senior living communities may benefit from increased occupancy and rates.
• Creditors will be monitoring DHC's ability to manage its debt and maintain liquidity.

Next Steps

• DHC will hold a conference call on May 7, 2024, to discuss the first quarter 2024 financial results.
• The company will continue to focus on strengthening its capital and liquidity position.
• DHC will continue to advance key initiatives to drive performance across its portfolio.

Key Dates

Keywords

Healthcare REIT, Senior Housing, Medical Office, Life Science, Real Estate Investment Trust, NOI, FFO, Occupancy, Rent Growth, EBITDAre